About Theradaptive
Theradaptive is a Healthcare company based in Boston (United States) founded in 2004. Therapeutic delivery platform is developed for orthopedic clinical indications. Theradaptive has raised $68.36 million across 7 funding rounds from investors including TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund. The company has 21 employees. Theradaptive offers products and services including Protein Engineering Platform, OASIS Trial, and Preclinical Studies. Its focus areas include Life Sciences, Drug Delivery, Implants and Orthopedics. Its legal entity is THERADAPTIVE, INC. Its competitors include MiMedx Group, EpiBone and RevBio; 2 of its 3 listed competitors have raised funding.
Company details
Theradaptive was founded in 2004 and is headquartered in Boston, United States. A therapeutic delivery platform is developed for various orthopedic clinical indications within the biotechnology sector. Solutions are offered for conditions such as spinal fusion, trauma repair, dental repair, and complex cartilage repair. Therapeutics are delivered to support targeted native tissue repair across multiple applications.
- Headquarters Boston, United States
- Employees 21
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website theradaptive.com
- Social LinkedIn
- Legal Name Theradaptive, Inc.
- Total Equity Funding$68.36M (USD)
in 7 rounds
- Latest Funding Round$36.16M (USD), Series B
Jul 2026
- InvestorsTEDCO
& 4 more
- Employee Count21
Products & Services of Theradaptive
Theradaptive offers a comprehensive portfolio of products and services, including Protein Engineering Platform, OASIS Trial, and Preclinical Studies.
Develops modified proteins for targeted therapeutic delivery in clinical applications.
Conducts trials for protein-based therapeutics in medical treatments.
Performs studies on protein variants for various indications.
Funding Insights of Theradaptive
Theradaptive has successfully raised a total of $68.36M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $36.16 million completed in July 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $68.36M
- Total Rounds 7
- Last Round Series B — $36.16M
- First Round $11.2M
(Jun 2018)
- Investors Count 5
All 7 funding rounds of Theradaptive with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2026 | $36.16M | Series B | – | – | – |
| May 2024 | Grant | – | – | ||
| Jul 2023 | $1M | Grant | – | – | |
| Jun 2023 | $26M | Series A | – | – | – |
| Jan 2021 | $6.2M | Series A | – | – | |
| Sep 2020 | $3M | Grant | – | – | |
| Jun 2018 | $11.2M | Grant | – | – |
5 investors in total: 5 institutional.
Investors in Theradaptive
Theradaptive has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include TEDCO, ORTHOREBIRTH and Maryland Stem Cell Research Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Stem cell research startups in healthcare are funded and accelerated. | mscrf.org | Columbia, United States | ||
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States | |
Cottony type synthetic bone void filling material | 2011 | orthorebirth.com | Yokohama, Japan | |
Military forces are provided by the U.S. Department of Defense for national security. | defense.gov | Washington, D.C., United States | ||
Administers health care and support for military personnel and operations. | health.mil | Falls Church, United States |
Investor details for Theradaptive
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Theradaptive
8 people are tracked at Theradaptive (6 in leadership, 2 in team); the tracked headcount is 21.
| Name | Role | Group |
|---|---|---|
David Stewart | Chief Operating Officer | Leadership |
Luis A. | Chief Executive Officer & Founder | Leadership |
Jill Dunty | Sr. Director Of Operations | Leadership |
Joseph R. Tamayo | Vice President Of Regulatory And Quality | Leadership |
Jonathan Elsner | Vice President Of Clinical Operations | Leadership |
Edward Fix | Vice President of Manufacturing | Leadership |
Salony Maniar | Project Manager | Team |
Justin Stewart | Clinical Trial Manager | Team |
Complete people profiles for Theradaptive
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Theradaptive
3 dated milestones of Theradaptive across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Theradaptive is founded.
- Funding First funding round of $11.2M.
- Funding Latest funding round, Series B, of $36.2M.
Competitors of Theradaptive
Theradaptive has 3 listed competitors in our database, 2 of them funded. They include MiMedx Group, EpiBone and RevBio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mimedx.com | 1985 | Marietta, United States | 735 | Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | ||
| epibone.com | 2013 | Brooklyn, United States | $48.63M | Developer of stem cells to regrow damaged bones | ||
| revbio.com | 2014 | Lowell, United States | $24.42M | Synthetic adhesives for bone and dental repair are developed. |
Detailed competitors of Theradaptive
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Theradaptive
The website of Theradaptive (theradaptive.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 35.3% vs previous month
Top companies in Orthopedics
3 companies that operate in the same segment as Theradaptive (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theradaptive
Complete news archive for Theradaptive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Theradaptive
Theradaptive was founded in 2004 and raised its 1st funding round 14 years after it was founded.
Theradaptive is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Theradaptive is a funded company, having raised a total of $68.36M across 7 funding rounds to date. The company's 1st funding round was a Grant of $11.2M, raised on Jun 2018.
Theradaptive has 21 employees.
Theradaptive was founded in 2004 and is headquartered in Boston, United States. A therapeutic delivery platform is developed for various orthopedic clinical indications within the biotechnology sector. Solutions are offered for conditions such as spinal fusion, trauma repair, dental repair, and complex cartilage repair. Therapeutics are delivered to support targeted native tissue repair across multiple applications.
Theradaptive's top competitors include EpiBone, MiMedx Group and RevBio.
Theradaptive offers Protein Engineering Platform, OASIS Trial, and Preclinical Studies.
Theradaptive has 5 investors. Key investors include TEDCO, ORTHOREBIRTH, Maryland Stem Cell Research Fund, U.S. Department of Defense, and Military Health.
Theradaptive operates through Theradaptive, Inc..